SCM
RGNX icon

Sterling Capital Management’s Regenxbio RGNX Stock Holding History

Sterling Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62K Sell
302
-1,257
-81% -$10.4K ﹤0.01% 2783
2026
Q1 		$13.1K Sell
1,559
-1,138
-42% -$12K ﹤0.01% 2235
2025
Q4 		$38.8K Sell
2,697
-531
-16% -$6.62K ﹤0.01% 1901
2025
Q3 		$31.1K Buy
3,228
+1,982
+159% +$17.5K ﹤0.01% 1939
2025
Q2 		$10.2K Buy
1,246
+444
+55% +$3.72K ﹤0.01% 2122
2025
Q1 		$5.73K Sell
802
-673
-46% -$5.01K ﹤0.01% 2093
2024
Q4 		$11.4K Buy
1,475
+1,315
+822% +$12.3K ﹤0.01% 2105
2024
Q3 		$1.68K Buy
+160
New +$1.95K ﹤0.01% 2265

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Sterling Capital Management's RGNX Position: Q2 2026 in Review

Sterling Capital Management reduced its Regenxbio (RGNX) stake by 81% in Q2 2026, selling an estimated $10.4K and leaving 302 shares worth $3.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2783.

Sterling Capital Management first reported a position in RGNX in Q3 2024 and has held it in 8 quarters since. The position peaked at $38.8K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Sterling Capital Management held 302 shares of Regenxbio worth $3.62K as of Q2 2026.
  • Sterling Capital Management sold 1,257 Regenxbio shares in Q2 2026, an estimated $10.4K.
  • Regenxbio made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2783 holding.
  • Sterling Capital Management first reported a position in Regenxbio in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Regenxbio position peaked at $38.8K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.